Insider Buys
This tool is in beta, validation in progress.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Score components and checks ✓/✗ are not accurate for every transaction yet.
Risk Factors Update Summary
- The company’s drawn amount under the Credit Agreement decreased from $490 million to $313 million, affecting liquidity.
- The company now faces risks from public health crises, which could significantly impact operations.
- The conflict in Gaza and trade tensions between the U.S. and China may negatively affect operations.
- Currency translation had a favorable effect of approximately $6 million on revenues due to dollar value changes.
- Research and development spending by customers may decline, impacting product demand and revenue.
- Changes to laws regarding laboratory developed tests may adversely affect business and financial results.
Full Text Changes in Most Recent 10-K
Intended use: review the highlighted statements. These are additions to the risk factors disclosure in the most recent 10-K filing compared to the previous 10-K filing. Deleted and moved text is less important and is shown for context.
To view the full company filings, click on the following link to be taken to the SEC EDGAR database landing page for the company: https://www.sec.gov/edgar/browse/?CIK=842023&owner=exclude
This content requires a 'Free' membership to view. Please create one here.
This content requires a 'Free' membership to view. Please create one here.